Evidence map›Paper›PMID 32698466›Full record

ArticleJournal of clinical medicine2020

Predictive Value of Serial ECGs in Patients with Suspected Myocardial Infarction.

Jonas Lehmacher, Johannes Tobias Neumann, Nils Arne Sörensen, Alina Goßling, Paul Michael Haller, Tau Sarra Hartikainen, Peter Clemmensen, Tanja Zeller, Stefan Blankenberg, Dirk Westermann

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jonas LehmacherDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
Johannes Tobias NeumannDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.ORCID 0000-0002-9478-2757
Nils Arne SörensenDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.ORCID 0000-0002-7571-4847
Alina GoßlingDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.ORCID 0000-0002-5211-5593
Paul Michael HallerDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
Tau Sarra HartikainenDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
Peter ClemmensenDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
Tanja ZellerDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
Stefan BlankenbergDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.
Dirk WestermannDepartment of Cardiology, University Heart and Vascular Center Hamburg, 20251 Hamburg, Germany.

Funding

Abbott Diagnostics unrestrictedDeutsches Zentrum für Herz-Kreislaufforschung unrestricted
6 · The paper itself

Abstract

The electrocardiogram (ECG) is an important diagnostic tool for patients with suspected acute myocardial infarction (AMI). Current guidelines recommend serial ECGs in case of persisting symptoms. We aimed to analyze the predictive value of ischemic ECG-signs in patients with suspected AMI. Patients presenting to the emergency department with suspected AMI were included. All patients with ST-elevation AMI were excluded from analyses. Patients received 12-lead-ECG and high-sensitive Troponin T (hs-TnT)-measurement at admission and after 3 h. Four groups were defined: no ischemic signs in either ECG; new ischemic signs in the second ECG; resolved ischemic signs in the second ECG; and persistent ischemic signs in both ECGs. Patients were followed for 2 years to assess the composite endpoint of all-cause-mortality, AMI, and coronary revascularization. Using a 30-day landmark analysis, a Cox regression with ischemic signs as the variable of interest, adjusted by cardiovascular risk factors, was calculated. Of 1675 patients, 1321 showed no ischemic signs, in 25 new-, in 92 resolved- and in 237 patients, persistent ischemic signs were documented. Patients with persistent ischemic signs had significantly worse outcomes, compared to those without. Compared to no ischemic signs, adjusted hazard ratios for the combined endpoint were 0.81 (95% CI 0.20, 3.31;

Indexed as

acute coronary syndromeelectrocardiographymyocardial infarctionoutcome

Identifiers

PMID32698466
PMCPMC7408822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.